Frontiers in Molecular Neuroscience (Mar 2023)

Serum miRNA modulations indicate changes in retinal morphology

  • Riemke Aggio-Bruce,
  • Riemke Aggio-Bruce,
  • Ulrike Schumann,
  • Ulrike Schumann,
  • Adrian V. Cioanca,
  • Fred K. Chen,
  • Fred K. Chen,
  • Fred K. Chen,
  • Fred K. Chen,
  • Samuel McLenachan,
  • Samuel McLenachan,
  • Rachael C. Heath Jeffery,
  • Rachael C. Heath Jeffery,
  • Rachael C. Heath Jeffery,
  • Shannon Das,
  • Riccardo Natoli,
  • Riccardo Natoli

DOI
https://doi.org/10.3389/fnmol.2023.1130249
Journal volume & issue
Vol. 16

Abstract

Read online

BackgroundAge-related macular degeneration (AMD) is the leading cause of vision loss in the developed world and the detection of its onset and progression are based on retinal morphological assessments. MicroRNA (miRNA) have been explored extensively as biomarkers for a range of neurological diseases including AMD, however differences in experimental design and the complexity of human biology have resulted in little overlap between studies. Using preclinical animal models and clinical samples, this study employs a novel approach to determine a serum signature of AMD progression.MethodsSerum miRNAs were extracted from mice exposed to photo-oxidative damage (PD; 0, 1, 3 and 5 days), and clinical samples from patients diagnosed with reticular pseudodrusen or atrophic AMD. The expression of ~800 miRNAs was measured using OpenArray™, and differential abundance from controls was determined using the HTqPCR R package followed by pathway analysis with DAVID. MiRNA expression changes were compared against quantifiable retinal histological indicators. Finally, the overlap of miRNA changes observed in the mouse model and human patient samples was investigated.ResultsDifferential miRNA abundance was identified at all PD time-points and in clinical samples. Importantly, these were associated with inflammatory pathways and histological changes in the retina. Further, we were able to align findings in the mouse serum to those of clinical patients.ConclusionIn conclusion, serum miRNAs are a valid tool as diagnostics for the early detection of retinal degeneration, as they reflect key changes in retinal health. The combination of pre-clinical animal models and human patient samples led to the identification of a preliminary serum miRNA signature for AMD. This study is an important platform for the future development of a diagnostic serum miRNA panel for the early detection of retinal degeneration.

Keywords